1. Home
  2. EXAS vs SBAC Comparison

EXAS vs SBAC Comparison

Compare EXAS & SBAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$103.38

Market Cap

19.6B

Sector

Health Care

ML Signal

HOLD

Logo SBA Communications Corporation

SBAC

SBA Communications Corporation

HOLD

Current Price

$196.91

Market Cap

19.7B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXAS
SBAC
Founded
1995
1989
Country
Employees
N/A
N/A
Industry
Medical Specialities
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
19.6B
19.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EXAS
SBAC
Price
$103.38
$196.91
Analyst Decision
Buy
Buy
Analyst Count
19
17
Target Price
$84.27
$235.65
AVG Volume (30 Days)
2.4M
894.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
2.21%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$19.40
$7.40
Revenue Next Year
$13.54
$1.36
P/E Ratio
N/A
$25.29
Revenue Growth
N/A
N/A
52 Week Low
$38.81
$177.49
52 Week High
$103.54
$245.16

Technical Indicators

Market Signals
Indicator
EXAS
SBAC
Relative Strength Index (RSI) 69.20 58.76
Support Level $103.14 $177.49
Resistance Level $103.87 $204.71
Average True Range (ATR) 0.35 5.59
MACD -0.12 2.10
Stochastic Oscillator 72.08 71.36

Price Performance

Historical Comparison
EXAS
SBAC

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About SBAC SBA Communications Corporation

SBA Communications owns a portfolio of about 45,000 wireless towers throughout North America, South America, and Africa. It leases space on its towers to wireless service providers, who install equipment to support their wireless networks. The company has a very concentrated customer base, with most revenue in each market being generated by the top few mobile carriers. It owns more than 17,000 towers in the US, which account for about 75% of leasing revenue. Internationally, SBA's largest presence is in Brazil, where it owns roughly 10,000 towers. SBA operates as a real estate investment trust.

Share on Social Networks: